Details

---

Manufacturer:
Duopharma (M) Sdn. Bhd., Malaysia

Content
rochlorperazine mesylate
 

Indications

• Management of nausea and vomiting, including those associated with chemotherapy, surgery, or migraines

• Treatment of vertigo and dizziness, particularly in conditions like Ménière’s disease

• Adjunctive therapy in psychotic disorders and short-term treatment of anxiety
  
   

Instructions 

• Administration Routes: Intravenous (IV) or intramuscular (IM) injection

• Storage: Store below 25°C, away from light and moisture; do not freeze

• Precautions: Use with caution in elderly patients, those with liver or kidney dysfunction, and during pregnancy unless necessary

• Side Effects: May include drowsiness, dizziness, extrapyramidal symptoms (e.g., muscle stiffness, tremors), and hypotension